logo

LINCARE HL(NSDQ:LNCR)
Lincare Holdings Inc. is one of the nation''s largest providers of oxygen and other respiratory therapy services to patients in the home. The company''s customers typically suffer from chronic obstructive pulmonary disease, such as emphysema, chronic bronchitis or asthma, and require supplemental oxygen or other respiratory therapy services in order to alleviate the symptoms and discomfort of respiratory dysfunction.
# Employees: 9957
Address: 19387 US 19 North,Clearwater,FL,USA
Phone: 727-530-7700
Fax: 727-532-9692
Website: www.lincare.com
Email: 1nfo@lincare.com
Sector: Medical
Industry: MED-OUTP/HM CRE
Executive Officers
John P. Byrnes (C.E.O.; P.E.O.; Dir.)
Paul G. Gabos (C.F.O.; Sec.; Princ Acctg. Off.)
Stuart H. Altman Ph.D (Dir.)
Frank D. Byrne M.D. (Dir.)
Chester B. Black (Dir.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 2/8/2010
Mean EPS (Next Qtr): $0.55
Mean EPS (Year): $1.97
Mean Estimate(Long Term): $16.67
P/E Ratio(Based on EPS estimate): 17.960
Number of Estimates: 9
Shares Performance
Period LNCR Compare to S&P
YTD 31.38 % 8.73 %
4 Weeks 10.39 % 9.20 %
12 Weeks 34.78 % 27.07 %
Shares Information
Analyst Coverage: Y
Avg Volume: 862727
Shares Outstanding: 67M
Market Cap: $2.40B
52 Week High: $35.97
52 Week Low: $19.70
P/E Ratio: 16.300
PEG Ratio: 1.080
Split: On 6/25/2001 LNCR split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: 8.16 %
EPS Growth in Last Year: -30.26 %
Sales Growth in Last Quarter: 3.23 %
Sales Growth in Last Quarter: -3.21 %
Financials
Qtr Book Value: $2.41
Cash Flow/Share: $7.36
Change in Payout Ratio: 0.000
Price/Sales: 1.540
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia